Back to results
US 2026/0232658 A1Published application
Azetidinyl benzoxazole compounds and their use as mer and axl inhibitors
AssigneeDong-A St Co., Ltd.
InventorsRobin R. FREY, Zhiqin JI, Yujia DAI, Julie M. MIYASHIRO, Thomas D. PENNING
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I) and an enantiomer, a diastereomer, a racemate, a tautomer, a prodrug, a hydrate, a solvate and pharmaceutically acceptable salts thereof, wherein L, R1, R2, R3 and W, are as defined in the specification, are useful in the treatment of diseases and conditions influenced by inhibition of Mer kinase, including cancer.
Claims21
A compound of formula (I), or an enantiomer, a diastereomer, a racemate, a tautomer, a prodrug, a hydrate, a solvate or a pharmaceutically acceptable salt thereof:
- where
- W is N or CH;
- L is selected from the group consisting of a bond, —CH═CHCRaRb—, —(CRaRb)n—O—, —(CRaRb)n—C(O)—, —O—, —O—(CRaRb)n—, —O—(CRaRb)n—O—, —OCH2C(O)—, and —C(O)—;
- each Ra is independently selected from the group consisting of hydrogen, C1-C4 alkyl, and C1-C2 hydroxyalkyl;
- each Rb is independently selected from the group consisting of hydrogen and C1-C4 alkyl;
- where Ra and Rb optionally combine to form a C3-6 cycloalkyl or 3-6 membered heterocycle;
- R1 is selected from the group consisting of H, C1-C6 alkyl, and 5-6 membered heterocyclyl;
- wherein the R1 C1-C6 alkyl is optionally substituted with 1 or 2 R4;
- R2 is selected from the group consisting of hydrogen, fluoro, chloro, bromo, and C1-C4 alkyl;
- R3 is selected from the group consisting of hydrogen, fluoro, chloro, bromo, —CN, C1-C4 alkyl, C1-C4 haloalkyl, —OH, —OR3a, —NR3bR3c, —P(O)(OR3d)2, —C(O)CHR3eNR3bR3c, —C(O)OH, —C(O)OR3a, —C(O)NR3bR3c, C3-C8 cycloalkyl, C5-C7 cycloalkenyl, 3-6 membered heterocyclyl, C5-C7 heterocycloalkenyl, C6 aryl, 5-6 membered heteroaryl and
- wherein the C3-C8 cycloalkyl, C6 aryl, 3-6 membered heterocyclyl, and 5-6 membered heteroaryl of R3, are optionally substituted with 1 or 2 of R5;
- R3a is C1-C4 alkyl;
- R3b and R3c are each independently selected from the group consisting of hydrogen, C1-C4 alkyl, C3-C6 cycloalkyl, and —CO2R3f;
- R3d is selected from the group consisting of hydrogen, C1-C4 alkyl, and C2-C4 alkenyl;
- R3e is selected from the group consisting of hydrogen and C1-C4 alkyl;
- wherein the C1-C4 alkyl of R3e is optionally substituted with 1 of R3g;
- R3f is C1-C4 alkyl;
- R3g selected from the group consisting of —OH, —SH, —SCH3, —NH2, —C(O)OH, —C(O)NH2, —NHC(NH)NH2, C6 aryl, and 5-9 membered heteroaryl;
- wherein the C6 aryl of R3g is optionally substituted with 1 of —OH;
- R4 is selected from the group consisting of —OH, —OR4a, —C(O)NR4bR4c, and 5-6 membered heterocyclyl;
- wherein the 5-6 membered heterocyclyl of R4 is optionally substituted with 1 or 2 of C1-C4 alkyl;
- R4a is C1-C4 alkyl;
- wherein the C1-C4 alkyl of R4a is optionally substituted with 1-Si(R4d)3;
- R4b and R4c are each independently selected from the group consisting of hydrogen and C1-C4 alkyl;
- R4d is C1-C4 alkyl;
- R5 is selected from the group consisting of fluoro, —CN, —OH, —OR5a, =O, —CH2CO2R5b, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 hydroxyalkyl, C1-C4 hydroxyalkoxy, and C2-C6 alkoxyalkyl;
- R5a is C1-C4 alkyl;
- and
- R5b is C1-C4 alkyl;
- n is an integer of 1 to 3.
27 more elements
-20. (canceled)
Dependencies are inferred from the claim text.